Click here to view the printer friendly version of this press release
NEW YORK--Manhattan Scientifics Inc. (OTCBB: MHTX), a nanomedicine technology transfer and commercialization pioneer, announced today that it has filed a Current Report on Form 8-K with the Securities Exchange Commission describing the terms of the company's recent milestone payment.
Manhattan Scientifics received a $1 million milestone payment from Carpenter Technologies, Inc. (CRS), the company's collaborative partner on nanometals technology for satisfying its performance obligations under the Technology Transfer Agreement between the parties dated August 12, 2009.
At a recent press conference the company also announced the official start of its production and sales of nanostructured titanium dental implants. The press conference is now available for viewing at the company's website and at the following link, http://www.mhtx.com/press-conference.htm.